Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04265872 |
| Title | Bortezomib Followed by Pembrolizumab and Cisplatin in metTNBC |
| Recruitment | Recruiting |
| Gender | female |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Baylor Research Institute |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Baylor University Medical Center, Baylor Charles A Sammons Cancer Center | RECRUITING | Dallas | Texas | 75246 | United States | Details |